Octaplas Approval History
FDA Approved: Yes (First approved January 17, 2013)
Brand name: Octaplas
Generic name: pooled plasma (human)
Dosage form: Solution for Intravenous Infusion
Treatment for: Bleeding Disorder
Octaplas is a solvent/detergent (S/D) treated, pooled human plasma indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies and plasma exchange in patients with thrombotic thrombocytopenic purpura.
Development History and FDA Approval Process for Octaplas
|Jan 17, 2013||FDA Approves Octaplas to Treat Patients with Blood Clotting Disorders|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.